Deal Alerts

Paksoy Deal Alerts

  1. Home
  2. News
  3. "Deal Alerts"
Practice Areas (All)
  • Antitrust and Competition (15)
  • Banking and Finance (32)
  • Capital Markets (50)
  • Corporate and Commercial (3)
  • Energy, Infrastructure and Projects (15)
  • FinTech (1)
  • Healthcare and Life Sciences (4)
  • Information Technologies, Internet Law and New Technologies (5)
  • Insurance and Private Pensions (3)
  • Islamic Finance (6)
  • Mergers and Acquisitions (111)
  • Private Equity (2)
  • Tax and Fiscal Services (18)
Related Person (All)
  • Aslı Eryılmaz (7)
  • Ayşe Demirel Atakan (6)
  • Ayşegül Avcı (1)
  • Bengisu Babalık (2)
  • Beril Paksoy (11)
  • Beritan Arık (13)
  • Berrak Çoşar (4)
  • Bülent Öztürk (15)
  • Canay Palak (1)
  • Cansın Taner (3)
  • Deniz Benli Kandiyoti (4)
  • Doğa Pınarlı Dedebaş (3)
  • Elvan Aziz (43)
  • Emre Açıkgöz (1)
  • Emre Kotil (1)
  • Gamze Boran (6)
  • Göktuğ Selvitopu (1)
  • Gülce Saydam Pehlivan (3)
  • Hazal Şenol (2)
  • Hüsna Çilova (3)
  • İrem Sabuncu (5)
  • Lale Ayrancıoğlu (4)
  • Melis Gençol İnce (12)
  • Melisa Sevinç Atılganer (10)
  • Meriç Saçak Albaş (6)
  • Mert Karakaşlar (2)
  • Merve Kurdak (26)
  • Mete Siber (5)
  • Mustafa Karadaş (4)
  • Nazlı Bezirci (21)
  • Nihan Bacanak (9)
  • Oğulcan Halebak (2)
  • Onur Berke Okur (2)
  • Ökkeş Şahan (26)
  • Ömer Çollak (34)
  • Pınar Babaoğlu (7)
  • Sabahattin Öztemiz (4)
  • Sabiha Ulusoy (2)
  • Sabri Kaya (4)
  • Selen Toma (5)
  • Sera Somay (43)
  • Serdar Ildırar (20)
  • Serdar Paksoy (2)
  • Serra Yıldırım (1)
  • Sibel Postacıoğlu (5)
  • Stéphanie Beghe Sönmez (23)
  • Şansal C. Erbacıoğlu (19)
  • Togan Turan (38)
  • Yeşeren Sözüer (5)
  • Zekican Samlı (9)
  • Zeynep Orta (1)
  • Zeynep Toma (6)
Year (All)
  • 2026 (14)
  • 2025 (26)
  • 2024 (21)
  • 2023 (23)
  • 2022 (14)
  • 2021 (30)
  • 2020 (12)
  • 2019 (20)
  • 2018 (20)

180 content

31 October 2025

Paksoy advised Borusan Next on the acquisition of Carvak

Paksoy advised Borusan Next on the acquisition of Carvak.

Read more

27 October 2025

Paksoy has advised the international syndicate consisting of IFC, AIIB, FMO and Green for Growth Fund, on the USD 340 million financing transaction with Enerjisa

Paksoy has advised the international syndicate consisting of IFC, AIIB, FMO and Green for Growth Fund, on the USD 340 million financing…

Read more

23 October 2025

Paksoy advised Türk Telekom on USD 600 million Green Notes offering due 2032

Paksoy advised Türk Telekom on USD 600 million Green Notes offering due 2032

Read more

22 October 2025

Paksoy has advised the international syndicate led by Bank of America, BNP Paribas and Société Générale on a USD 600 million loan to Koç Holding

Paksoy has advised the international syndicate led by Bank of America, BNP Paribas and Société Générale on a USD 600 million loan to Koç…

Read more

20 October 2025

Paksoy has advised Vakıf Katılım on its inaugural Additional Tier 1 sukuk issuance, valued at USD 500 million — the largest subordinated sukuk ever issued by a participation bank in Türkiye

Paksoy has advised Vakıf Katılım on its inaugural Additional Tier 1 sukuk issuance, valued at USD 500 million — the largest subordinated…

Read more

29 September 2025

Paksoy advises Merrill Lynch International on Vakıfbank share sale

Paksoy has advised the sole global coordinator and bookrunner, Merrill Lynch International, on the sale of 1.53% of the shares owned by…

Read more

17 September 2025

Paksoy advises Ege Kimya on its recent acquisitions of Venator Materials’ Driers Book of Business and 100% of the shares in Metal Oksit

Ege Kimya is a leading Turkish chemicals company with operations in intermediate chemicals serving both domestic and international markets.…

Read more

9 September 2025

Paksoy advises Parsan, a Güriş Holding company listed on Borsa Istanbul, on the merger with Omtaş

Parsan, a Güriş Holding group company listed on Borsa Istanbul and active in integrated steel forging and machining business, has now…

Read more

4 September 2025

Paksoy advises Solventum on sale of purification and filtration business to Thermo Fisher

Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to…

Read more

Privacy Preference Center

Cookie Preferences

We use cookies to improve your user experience on our website while respecting your privacy. Not allowing certain cookies may affect your experience. By continuing to visit this website, you agree to our use of cookies marked as “active” below and accept our Cookie Policy (accessible through our Terms and Conditions) without any restriction or objection.

Mandatory cookies

Always active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to your actions that imply a request for service, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or warn you about these cookies, but in this case some parts of the site will not work. These cookies do not store any personally identifiable information. You can access cookie details here.

Analytical cookies

Analytical cookies are used to understand how visitors interact with the website. These cookies help to provide information about metrics such as number of visitors, bounce rate, traffic source, etc. These cookies allow us to count visits and traffic sources so that we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and to see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies, we cannot know when you visit our site and we cannot monitor the performance of our site. You can access cookie details here.

Youtube

We use YouTube infrastructure to display podcast and video content. You can access cookie details here.

Spotify

We use Spotify infrastructure to display podcast content. You can access cookie details here.